Indivior shareholders approve scheme of arrangement to restructure, court hearing Jan 22, 2026

Indivior Pharmaceuticals, Inc.

Amended articles effective Dec 11 to facilitate scheme ensuring all shareholders become holders of Indivior Pharmaceuticals shares.
Court meeting: 94,968,161 votes for (99.9%) vs 46,544 against; passed by required majorities.
Extraordinary General Meeting: all 6 special resolutions passed with over 79 million votes for each.
Completion subject to High Court sanction hearing expected January 22, 2026.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Indivior Pharmaceuticals, Inc.: Amended and restated articles of association to add Article 136 for the purpose of facilitating the scheme of arrangement (effective 2025-12-11).

Change: charter amendment
Effective: 2025-12-11

Exact text from the filing

On December 11, 2025 shareholders of Indivior PLC (the "Company" or the "Registrant") approved amended and restated articles of association (the “Amended Articles”). The amendments introduced a new Article 136 for the purpose of facilitating the scheme of arrangement as set out in the shareholder circular published on November 14, 2025 (the “Scheme of Arrangement”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Indivior Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001625297-25-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.